 Provider News ColoradoJanuary 2023 Anthem Provider News - ColoradoAs a reminder, we will update our claim editing software for professional services throughout 2023, with most updates occurring at a minimum quarterly. These updates apply to any provider, provider group (tax identification number) and/or across providers and claim type (professional/facility) and include, but are not limited to: - The addition of new, and revised codes (for example, CPT®, HCPCS, ICD-10, modifiers) and associated edits such as:
- ICD-10 laterality
- Add-on procedures (indicated by + sign)
- Code book parenthetical statements and other directives about appropriate code use (for example, separate procedure, do not report, list separately in addition to, etc.)
- Updates to editing for multiple procedure reduction calculations based on relative value unit (RVU) as designated and updated by the Centers for Medicare & Medicaid (CMS) in the physician fee schedule relative value (PFSRV) files
- Updates to National Correct Coding Initiative edits (NCCI) and medically unlikely edits (MUEs)
- Updates to incidental, mutually exclusive, and unbundled (re-bundle) edits
- Updates to code edits associated with reimbursement policies including, but not limited to, updates to the edits that allow/disallow for assistant surgeon/co-surgeon/team surgeon, frequency edits, bundled services and global surgery preoperative and post-operative periods assigned by CMS
As a reminder, we will update our claim editing software for outpatient facility services throughout 2023 with most updates occurring at a minimum quarterly. These updates will include, but are not limited to: - The addition of new and revised codes (for example, CPT®, HCPCS, ICD-10, modifiers, revenue codes) and associated edits.
- Updates related to the appropriate use of various code combinations, which can include, but are not limited to, CPT/HCPCS code to revenue code, type of bill to procedure code, type of bill to CPT/HCPCS code, and CPT/HCPCS code to modifier.
- Updates to National Correct Coding Initiative edits (NCCI) and Facility Outpatient Hospital Services Medically Unlikely Edits (MUEs).
- Updates to reflect coding requirements as designated by industry standard sources such as the National Uniform Billing Committee (NUBC) and the Centers for Medicare & Medicaid Services (CMS).
In November 2022, we shared information about updates to claim status inquiries denial descriptions. You should now see these expanded descriptions on your explanation of payment remittance advice. These simplified descriptions should make it easier to understand why your claim denied and how to update your claim with the information needed for processing. We’re phasing in clear, concise, and simplified denial descriptions that explain in greater detail why the claim or claim line has denied and what to do next. We’ve even included details about how to provide us with information digitally, to move the claim further along in the claims process. Continuing to improve The new denial descriptions will be phased in over the next few months. We’re starting with those claims or claim lines that have caused the most confusion based on your feedback. If new denial reasons are added, those descriptions will be expanded, as well. Save time. Increase efficiency. Go digital! If you’re not enrolled in Availity* Essentials, use this link for registration information: https://availity.com/Essentials-Portal-Registration. There is no cost for our providers to use the applications through Availity.com.
* Availity, LLC is an independent company providing administrative support services on behalf of Anthem Blue Cross and Blue Shield. MULTI-BCBS-CM-014766-22 Why is this important? Each year, a random sample of enrolled members receive a CAHPS* Survey or a Qualified Health Plan Enrollee Survey asking them to evaluate their experiences with healthcare. The surveys ask members to rate their experiences with: - Their health plan.
- Their personal provider.
- Their specialist.
Several responses are combined and evaluated for the following: - Getting needed care
- Receiving care quickly
- Communicating with providers
- Sharing in the decision-making process
The responses give us an idea of how your patients and our members perceive us and provide opportunities for us to improve the way we deliver services. Our engagement and interaction with patients and members are critical. Together, we can provide positive experiences for our shared members and patients. Members receive the survey either by mail or phone between February and May. Some of the questions they are asked include: - In the last six1 months, how often did your personal provider explain things in a way that was easy to understand?
- In the last six1 months, how often did your personal provider listen carefully to you?
- In the last six1 months, how often did your personal provider show respect for what you had to say?
- In the last six1 months, how often did your personal provider spend enough time with you?
- Using any number from zero to 10, where zero is the worst personal provider possible, and 10 is the best personal provider possible, what number would you use to rate your personal doctor?
- We want to know your rating of the specialist you saw most often in the last six1 months. Using any number from zero to 10, where zero is the worst specialist possible and 10 is the best specialist possible, what number would you use to rate the specialist?
Every interaction with a patient is an opportunity to make their healthcare experience positive. We thank you for striving to provide quality care for our members and for the continued focus on improving our member experience. Additional information Continuing medical education (CME) education opportunities: http://www.mydiversepatients.com.
* CAHPS® is a registered trademark of the Agency for Healthcare Research and Quality (AHRQ). MULTI-BCBS-CRCM-008629-22-CPN6881 Effective January 1, 2023, all large group, fully insured health benefit plans, to include student health plans, issued or renewed in the state of Colorado must provide coverage for the diagnosis of and treatment for infertility and standard fertility preservation services. Coverage required includes three completed oocyte retrievals, per year, irrespective of benefit or calendar year, with unlimited embryo transfers in accordance with the guidelines of the American Society for Reproductive Medicine (ASRM), using single embryo transfer when recommended and medically appropriate.
The health plan cannot impose:
- Any exclusions, limitations, or other restrictions on coverage of fertility medications that are different from the exclusions, limitations, or other restriction imposed on any other prescription medications covered under the health benefit plan.
- Deductibles, copayments, coinsurance, benefit maximums, waiting periods, or other limitations on coverage for the diagnosis of and treatment for infertility and standard fertility preservation services, which are different from deductibles, copayments, coinsurance, benefit maximums, waiting periods, or other limitations imposed on benefits for services covered under the health benefit plan that are not related to infertility.
The bill does allow religious exemptions. A religious employer may request, and a carrier must grant, an exclusion if the required coverage conflicts with the religious organization’s genuine religious beliefs and practices. A religious employer who obtains an exclusion must provide its employees reasonable and timely notice of the exclusion of the coverage.
Note: Balance-funded plans for Anthem Blue Cross and Blue Shield typically follow rules for fully insured plans. Administrative services only (ASO) groups can opt out of this coverage using a rider.
HEDIS® measurement year 2023 documentation for Childhood Immunization Status (CIS) Measure description:The percentage of children who turn 2 years of age in the measurement year who had the following vaccines on or before their second birthday: - Four DTaP (diphtheria, tetanus, and acellular pertussis)
- Three IPV (polio)
- One MMR (measles, mumps, and rubella)
- Three HiB (haemophilus influenza type B)
- Three hep B (hepatitis B)
- One VZV (chicken pox)
- Four PCV (pneumococcal conjugate)
- One hep A (hepatitis A)
- Two or three RV (rotavirus)
- Two flu (influenza)
The measure calculates a rate for each vaccine and three combination rates. HEDIS measurement year 2023 documentation for Lead Screening in Children (LSC) Measuredescription: The percentage of children 2 years of age who had one or more capillary or venous lead blood test for lead poisoning by their second birthday. In provider medical records, we look for the following: - Immunization records from birth (Department of Health immunization records are acceptable).
- If available, newborn inpatient records documenting hepatitis B.
- For immunizations not recorded on the immunization record, provide progress notes for:
- Immunizations administered.
- Patient’s history of disease (chickenpox, hep A, hep B, measles, mumps, rubella).
- Lead testing results and date (capillary or venous) on or before the second birthday.
- Evidence of hospice services in 2023.
- Evidence patient expired in 2023.
Helpful hints: - Childhood immunizations and lead blood tests must be completed by child’s second birthday.
- Assess immunization needs at every clinical encounter and, when indicated, immunize.
- Ensure immunization records include all vaccines that were ever given including hospitals, health departments, and all former providers, including refusals and contraindications.
- FluMist (LAIV) vaccination (only approved for ages 2 to 49) may be used for the second vaccination; however, it must be given on the child’s second birthday to be compliant.
HEDIS® is a registered trademark of the National Committee for Quality Assurance (NCQA). MULTI-BCBS-CRCM-012261-22-CPN11878 As previously communicated in the November 2022 edition of Provider News, AIM Specialty Health ®* (AIM) will apply additional code updates to the AIM Specialty Health Diagnostic Coronary Angiography and Percutaneous Coronary Intervention Clinical Appropriateness Guidelines. That code update expansion has been delayed. The codes listed below will go into effect April 1, 2023, not February 1, 2023, as originally communicated.
Percutaneous coronary intervention:
CPT code
|
Description
|
92975
|
Thrombolysis, coronary; by intracoronary infusion, including selective coronary angiography
|
C9600
|
Percutaneous transcatheter placement of drug eluting intracoronary stent(s), with coronary angioplasty when performed; single major coronary artery or branch
|
C9601
|
Percutaneous transcatheter placement of drug-eluting intracoronary stent(s), with coronary angioplasty when performed; each additional branch of a major coronary artery (list separately in addition to code for primary procedure)
|
C9602
|
Percutaneous transluminal coronary atherectomy, with drug eluting intracoronary stent, with coronary angioplasty when performed; single major coronary artery or branch
|
C9603
|
Percutaneous transluminal coronary atherectomy, with drug-eluting intracoronary stent, with coronary angioplasty when performed; each additional branch of a major coronary artery (list separately in addition to code for primary procedure)
|
C9604
|
Percutaneous transluminal revascularization of or through coronary artery bypass graft (internal mammary, free arterial, venous), any combination of drug-eluting intracoronary stent, atherectomy and angioplasty, including distal protection when performed; single vessel
|
C9605
|
Percutaneous transluminal revascularization of or through coronary artery bypass graft (internal mammary, free arterial, venous), any combination of drug-eluting intracoronary stent, atherectomy and angioplasty, including distal protection when performed; each additional branch subtended by the bypass graft (list separately in addition to code for primary procedure)
|
C9607
|
Percutaneous transluminal revascularization of chronic total occlusion, coronary artery, coronary artery branch, or coronary artery bypass graft, any combination of drug-eluting intracoronary stent, atherectomy and angioplasty; single vessel
|
C9608
|
Percutaneous transluminal revascularization of chronic total occlusion, coronary artery, coronary artery branch, or coronary artery bypass graft, any combination of drug-eluting intracoronary stent, atherectomy and angioplasty; each additional coronary artery, coronary artery branch, or bypass graft (list separately in addition to code for primary procedure)
|
C1714
|
Catheter, transluminal atherectomy, directional
|
C1724
|
Catheter, transluminal atherectomy, rotational
|
C1725
|
Catheter, transluminal angioplasty, non-laser (may include guidance, infusion/perfusion capability)
|
C1753
|
Catheter, intravascular ultrasound
|
C1760
|
Closure device, vascular (implantable/insertable)
|
C1761
|
Catheter, transluminal intravascular lithotripsy, coronary
|
C1769
|
Guide wire
|
C1874
|
Stent, coated/covered, with delivery system
|
C1875
|
Stent, coated/covered, without delivery system
|
C1876
|
Stent, non-coated/non-covered, with delivery system
|
C1877
|
Stent, non-coated/non-covered, without delivery system
|
C1885
|
Catheter, transluminal angioplasty, laser
|
C1887
|
Catheter, guiding (may include infusion/perfusion capability)
|
- Access AIM’s ProviderPortalSM directly at providerportal.com.
- Online access is available 24/7 to process orders in real-time and is the fastest and most convenient way to request authorization.
- Call the AIM Contact Center toll-free number at 877-291-0366, Monday through Friday, from 8 a.m. to 6 p.m. Mountain time.
For questions related to guidelines, contact AIM via email at aim.guidelines@aimspecialtyhealth.com. Additionally, you may access and download a copy of the current and upcoming guidelines here.
Effective for dates of service on and after April 9, 2023, the following updates will apply to the AIM Specialty Health®* Cardiology Clinical Appropriateness Guidelines. As part of the AIM guideline annual review process, these updates are focused on advancing efforts to drive clinically appropriate and affordable healthcare services. Cardiac Imaging — Updates by section Stress testing with imaging: - Suspected coronary artery disease (CAD) without symptoms — Indications removed
- Suspected CAD with symptoms — Indications modified
- Need for testing determined by pretest probability
- Definition of chest pain expanded to include ischemic equivalent pain elsewhere
- Dyspnea included as standalone symptom
- Imaging modality to be selected by the treating physician
- Exercise preferred over pharmacologic testing in patients referred for stress testing with imaging
- Patients with atypical symptoms to undergo non-imaging stress testing (assuming capable of exercise and no precluding resting EKG abnormalities)
- Established CAD without symptoms — Indications removed
- Established CAD with symptoms — Indications removed
CT coronary angiography (CCTA): - Indications added — Considerable expansion in use for evaluation of CAD (now a first-line modality)
- Indications added — Preoperative testing indications
- Indications added — Abnormal prior testing indications
- Indications removed — Suspected anomalous coronary arteries (basis for suspicion required)
Fractional Flow Reserve from CCTA (FFR-CT): - Indication modified — 40% to 90% coronary stenosis in symptomatic patient who has failed guideline-directed medical therapy and has undergone CCTA within preceding 90 days
Stress Cardiac MRI: - Indications added — Considerable expansion in use for evaluation of CAD (now a first-line modality)
- Indications added — Preoperative testing indications
- Indications added — Abnormal prior testing indications
Resting Cardiac MRI: - Indication added — Fabry disease
- Indications modified — Suspected myocarditis (basis for suspicion required)
- Indications modified — Arrhythmogenic right ventricular dysplasia (ARVD) requirements clarified
- Indications modified — Suspected anomalous coronary arteries (basis for suspicion required)
Resting transthoracic echocardiography (TTE): - Valvular heart disease — updated frequency of surveillance in patients with prosthetic valves and those who had transcatheter valve replacement/repair; removed requirement of valvular dysfunction for those who had surgical mitral valve repair; removed moderate/severe mitral regurgitation for those who had transcatheter mitral valve repair
Diagnostic Coronary Angiography: - Indications modified — Clarification that patients with established CAD who have failed GDMT may undergo coronary angiography regardless of how initial diagnosis was made
As a reminder, ordering and servicing providers may submit prior authorization requests to AIM by accessing AIM’s ProviderPortalSM directly at www.providerportal.com:
- Online access is available 24/7 to process orders in real-time and is the fastest and most convenient way to request authorization.
If you have questions related to guidelines, please contact AIM via email at aim.guidelines@aimspecialtyhealth.com. Additionally, you may access and download a copy of the current and upcoming guidelines here.
* AIM Specialty Health is an independent company providing some utilization review services on behalf of Anthem Blue Cross and Blue Shield. MULTI-BCBS-CM-012489-22-CPN11939 Material Adverse Change (MAC)
Beginning with dates of service on or after April 1, 2023, or the end of the public health emergency (PHE), whichever is later, reimbursement for COVID-19 laboratory service codes may be reduced for participating providers contracted with Anthem.
New COVID-19 laboratory service codes were implemented and reimbursed at rates to meet the needs of providers during the PHE. Reimbursement will now be revised to Anthem's standard reimbursement methodology for the following codes:
U0001
|
86328
|
87426
|
87811
|
0226U
|
U0002
|
86408
|
87428
|
0202U
|
0240U
|
U0003
|
86409
|
87635
|
0223U
|
0241U
|
U0004
|
86413
|
87636
|
0224U
|
|
U0005
|
86769
|
87637
|
0225U
|
|
If you have any questions regarding this notice, please contact Provider Services or use Availity* Live Chat, which is available during normal business hours. Go to www.availity.com and select Anthem from the payer spaces drop-down. Then, select Chat with Payer and complete the pre-chat form to start your chat.
Material adverse change
Effective for dates of service on and after April 9, 2023, the following updates will apply to the AIM Specialty Health®* Rehabilitative and Habilitative Services Clinical Appropriateness Guidelines. As part of the AIM guideline annual review process, these updates are focused on advancing efforts to drive clinically appropriate, safe, and affordable healthcare services.
Rehabilitative and habilitative services — updates by section
- Clarified language about the background of speech-language professionals
- Clarified language about qualified speech-language pathology providers
Speech therapy alternative treatments:
- Clarified language about qualified speech providers
- Definition of blue dye test clarified
- Parkinson Voice Project definition expanded
Physical therapy and occupational therapy adjunctive treatments:
- Added definition of Lee Silverman Voice Treatment BIG — proprietary program of intensive physical and/or occupational therapy of at least one month duration involving large, full-body exercises to improve functional movement and self-care tasks of people with Parkinson’s disease and other neurological conditions. It requires company-certification of providers.
- Added exclusion for Lee Silverman Voice treatment
As a reminder, ordering and servicing providers may submit prior authorization requests to AIM:
- Access AIM’s ProviderPortalSM directly at providerportal.com:
- Online access is available 24/7 to process orders in real-time and is the fastest and most convenient way to request authorization.
If you have questions related to guidelines, please contact AIM via email at aim.guidelines@aimspecialtyhealth.com. Additionally, you may access and download a copy of the current and upcoming guidelines here.
|